Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct;20(5):493-9.
doi: 10.1007/s40291-016-0217-0.

A Simple Method for TPMT and ITPA Genotyping Using Multiplex HRMA for Patients Treated with Thiopurine Drugs

Affiliations

A Simple Method for TPMT and ITPA Genotyping Using Multiplex HRMA for Patients Treated with Thiopurine Drugs

Marzena Skrzypczak-Zielinska et al. Mol Diagn Ther. 2016 Oct.

Abstract

Thiopurine methyltransferase (TPMT) and inosine triphosphatase (ITPA) are crucial enzymes involved in the metabolism of thiopurine drugs: azathioprine and 6-mercaptopurine, used in the treatment of leukemia or inflammatory bowel diseases (IBD). The activity in these enzymes correlates with the genetic polymorphism of the TPMT and ITPA genes, respectively, which determines an individual reaction and dosing of thiopurines. Three main TPMT alleles: TPMT*2 (c.238G>C), TPMT*3A (c.460G>A, c.719A>G) and TPMT*3C (c.719A>G) account for 80-95 % of inherited TPMT deficiency in different populations in the world. In the ITPA gene, a c.94C>A mutation is significantly associated with an adverse thiopurine reaction. The aim of this study was to develop a quick and highly sensitive method for determining major TPMT and ITPA alleles. Here we present the molecular test for genotyping c.238G>C, c.460G>A, c.719A>G and c.94C>A changes based on multiplex high resolution melting analysis (HRMA). We analyzed DNA samples from 100 clinically diagnosed IBD patients treated with thiopurine drugs, and a known genotype in the positions 238, 460 and 719 of the TPMT gene as well as in position 94 of the ITPA gene. Our results obtained with multiplex HRMA indicated 100 % accuracy in comparison with data from restriction fragments length polymorphism (RFLP) and standard DNA sequencing. We conclude, that multiplex HRMA can be used as a quick, sensitive and efficient alternative diagnostic method compared to conventional techniques for the determination of TPMT*2, TPMT*3A and TPMT*3C alleles and c.94C>A change in the ITPA gene.

PubMed Disclaimer

Conflict of interest statement

Compliance with Ethical StandardsConflict of interestThe authors MSZ, PB, ABK, OZB, MW, AD, MK, MW, DL, AP and RS declare no conflicts of interest.Ethical approval and informed consentAll patients declared informed consent and the studies were approved by the local Ethics Committee of the Poznan University of Medical Sciences (Approval No. 871/09).FundingThe studies was funded by a Grant from the Polish Ministry of Science and Higher Education (Grant No. N N402209835).

Figures

Fig. 1
Fig. 1
Multiplex high resolution melting (HRM) analysis for exon 6 and 9 of the TPMT gene. a Melting profile of both polymerase chain reaction (PCR) products. b Normalized difference plots of amplicons corresponding to exon 9 (c.719). c Normalized difference plots of amplicons corresponding to exon 6 (c.460 and additionally locus c.474)
Fig. 2
Fig. 2
Multiplex high resolution melting analysis (HRMA) for exon 4 of the TPMT gene and exon 2 of the ITPA gene. a Melting profile of both polymerase chain reaction (PCR) products. b Normalized difference plots of amplicons corresponding to exon 4 (c.238). c Normalized difference plots of amplicons corresponding to exon 2 (c.94)

Similar articles

Cited by

References

    1. Sahasranaman S, Howard D, Roy S. Clinical pharmacology and pharmacogenetics of thiopurines. Eur J Clin Pharmacol. 2008;64:753–767. doi: 10.1007/s00228-008-0478-6. - DOI - PubMed
    1. Lafolie P, Hayder S, Björk O, Ahström L, Liliemark J, Peterson C. Large interindividual variations in the pharmacokinetics of oral 6-mercaptopurine in maintenance therapy of children with acute leukaemia and non-Hodgkin lymphoma. Acta Paediatr Scand. 1986;75(5):797–803. doi: 10.1111/j.1651-2227.1986.tb10293.x. - DOI - PubMed
    1. Weinshilboum RM, Sladek SL. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet. 1980;32:651–662. - PMC - PubMed
    1. Kim HY, Lee SH, Lee MN, Kim JW, Kim YH, Kim MJ, et al. Complete sequence-based screening of TPMT variants in the Korean population. Pharmacogenet Genomics. 2015;25(3):143–146. doi: 10.1097/FPC.0000000000000117. - DOI - PubMed
    1. Yates CR, Krynetski EY, Loennechen T, Fessing MY, Tai HL, Pui CH, Relling MV, Evans WE. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med. 1997;126:608–614. doi: 10.7326/0003-4819-126-8-199704150-00003. - DOI - PubMed

Publication types

LinkOut - more resources